Clozapine is widely considered the most effective treatment for patients with severe schizophrenia. But across the U.S., people were repeatedly denied access to it because of a federal monitoring system that could block prescriptions over missed or delayed blood tests. Despite recent reforms, decades of stigma and a fragmented mental health system continue to reinforce the medication’s status as a drug of last resort.
